ストックスクリーナーアプリを入手
3.05
2.56%
-0.08
プレマーケット:
3.10
0.05
+1.64%
前日終値:
$3.13
開ける：
$3.15
24時間の取引高:
279.03K
Relative Volume:
0.65
時価総額：
$149.72M
収益：
$226.63M
当期純損益:
$15.38M
株価収益率:
-61.00
EPS:
-0.05
ネットキャッシュフロー:
$35.61M
1週間 パフォーマンス:
+0.99%
1か月 パフォーマンス:
-10.03%
6か月 パフォーマンス:
-6.44%
1年 パフォーマンス:
-29.56%
1日の値動き範囲:
$2.99
$3.1696
1週間の範囲:
$2.89
$3.38
52週間の値動き範囲:
$2.225
$7.73
Puma Biotechnology Inc Stock (PBYI) Company Profile
名前
Puma Biotechnology Inc
セクター
電話
(424) 248-6500
住所
10880 WILSHIRE BLVD., LOS ANGELES, CA
PBYI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
3.05 | 149.72M | 226.63M | 15.38M | 35.61M | 0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
402.70 | 103.71B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
712.33 | 78.28B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
615.00 | 36.77B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.31 | 30.35B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.95 | 27.32B | 3.30B | -501.07M | 1.03B | -2.1146 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-09-28 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-25 | 再開されました | BofA/Merrill | Underperform |
| 2019-10-08 | ダウングレード | Goldman | Neutral → Sell |
| 2019-05-10 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-01-17 | 開始されました | Leerink Partners | Mkt Perform |
| 2019-01-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2018-11-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-11-02 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-09-17 | 開始されました | Goldman | Sell |
| 2018-05-11 | 繰り返されました | Stifel | Buy |
| 2017-11-10 | 繰り返されました | Citigroup | Buy |
| 2017-11-10 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | 繰り返されました | Stifel | Buy |
| 2017-09-11 | 繰り返されました | Credit Suisse | Outperform |
| 2017-07-10 | 再開されました | Leerink Partners | Outperform |
| 2017-06-06 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
すべてを表示
Puma Biotechnology Inc (PBYI) 最新ニュース
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - MSN
All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong Buy - Yahoo Finance
Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - MSN
Puma biotechnology sales earnings call - Ciudad Florida
Research Analysts Set Expectations for PBYI FY2025 Earnings - Defense World
What Every Investor Should Know: Understanding ROE Can Change Your Game! - Clinique Bio
Best Value Stocks to Buy for December 24th - MSN
Zacks Research Has Positive Outlook of PBYI FY2025 Earnings - MarketBeat
Should You Be Excited About Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 33% Return On Equity? - Simply Wall St
Puma Biotech shares hold as analyst backs Buy rating on NCCN nod - Investing.com Canada
Puma Biotechnology (NASDAQ:PBYI) Given “Buy” Rating at HC Wainwright - Defense World
Best Momentum Stocks To Buy For December 24th - Barchart
Best Momentum Stocks to Buy for December 24th - Yahoo Finance
With 49% stake, Puma Biotechnology, Inc. (NASDAQ:PBYI) seems to have captured institutional investors' interest - Yahoo Finance
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation - Business Wire
XTX Topco Ltd Sells 22,227 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Acquired by Fmr LLC - Defense World
Puma Biotechnology: The Best Performing Biotechs of 2013 - AOL
Charles Schwab Investment Management Inc. Sells 8,574 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Bought by BNP Paribas Financial Markets - Defense World
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance
Puma biotechnologies 2025 - detikawanua.com
Puma Biotechnology: Continuing To Push Their Aurora Kinase Story Forward - Seeking Alpha
Puma Biotechnology (NASDAQ:PBYI) Lowered to Buy Rating by StockNews.com - MarketBeat
HRMY: 3 Emerging Biotech Stocks Developing Breakthrough Therapies - StockNews.com
PBYIPUMA BIOTECHNOLOGY INC Latest Stock News & Market Updates - StockTitan
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Bakersfield Californian
Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance
Discovering Promising US Penny Stocks In November 2024 - Simply Wall St
Puma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.com to Buy - MarketBeat
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN
Puma commences Phase II trial of alisertib for breast cancer treatment - Clinical Trials Arena
Puma Biotech Launches Phase 2 Trial for Advanced Breast Cancer Treatment | PBYI Stock News - StockTitan
Puma Biotechnology Announces Initiation of ALISCA -Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer - Business Wire
245,695 Shares in Puma Biotechnology, Inc. (NASDAQ:PBYI) Bought by Los Angeles Capital Management LLC - MarketBeat
Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance
Puma Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Puma Biotechnology reports robust Q3 growth - Investing.com
Earnings call: Puma Biotechnology reports robust Q3 growth By Investing.com - Investing.com UK
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Nasdaq
Puma Biotechnology Reports Strong Q3 2024 Growth - TipRanks
Puma Biotechnology Q3 2024 Earnings Preview - MSN
Puma Biotech (PBYI) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Puma Biotechnology Reports Third Quarter 2024 Financial Results - sharewise
Puma Biotech: Q3 Earnings Snapshot - San Francisco Chronicle
Puma Biotechnology Inc (PBYI) 財務データ
収益
当期純利益
現金流量
EPS
0.48%
1.34%
大文字化:
|
ボリューム (24 時間):